# OnCo record johann-de-bono (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/johann-de-bono/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "johann-de-bono" ;
  schema:name "Johann de Bono"@en ;
  schema:description "Johann de Bono led the trials that brought abiraterone and olaparib to prostate cancer patients."@en ;
  schema:url <https://onco.cc/people/johann-de-bono/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://www.icr.ac.uk/research-and-discoveries/our-research/researchers/professor-johann-de-bono>, <https://pubmed.ncbi.nlm.nih.gov/?term=de%20Bono%20JS%5BAuthor%5D%20prostate> ;
  schema:jobTitle "Regius Professor of Cancer Research, ICR; Head of Drug Development Unit, Royal Marsden" ;
  schema:sameAs <https://orcid.org/0000-0002-2034-595X> ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:technologies <https://onco.cc/technologies/parp-inhibitor/>, <https://onco.cc/technologies/androgen-deprivation/> ;
  onco:targets <https://onco.cc/targets/androgen-receptor/>, <https://onco.cc/targets/parp/>, <https://onco.cc/targets/brca/> ;
  onco:drugs <https://onco.cc/drugs/abiraterone/>, <https://onco.cc/drugs/olaparib/> ;
  onco:institutions <https://onco.cc/institutions/royal-marsden/>, <https://onco.cc/institutions/icr-london/> ;
  onco:trials <https://onco.cc/trials/profound/> ;
  schema:affiliation <https://onco.cc/institutions/royal-marsden/> .
